Bringing the fundamentals into focus…
Back to Varex Imaging Corporation
How Varex Imaging Corporation stacks up
VREX · against 484 other Healthcare companies of similar size
Valuation
69/ 100
Above the middle of the pack.
Ranked #167 of 485 · scores higher than 65% of peers
Bars: peers in each 10-point band of the valuation score36 peers with a valuation score of 60–69, including VREX · Click a bar to see the companies
Why valuation scores 69?
Weighted metrics compared with all Healthcare companies.Mainly thanks to its EBITDA yield and earnings yield, which are stronger than most Healthcare peers.
- Negative (a loss or cash outflow), so it counts as zero whatever the share price. Free cash flow yield: -2.6% vs peer median 0.0%
- higher earnings for the price paid: stronger than 61% of peers. Earnings yield: 2.8% vs peer median 1.5%
- more operating profit (EBITDA) for the company's total value: stronger than 77% of peers. EBITDA yield: 9.7% vs peer median 4.0%
Metric by metric
Position: dot = VREX, ranked from the worst peer (left) to the best (right); tick = middle, shaded = middle half of peers.| Metric | VREX | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Earnings yieldHigher is better · 473 reported | 2.9% | 1.1% | 62% | 30% | |
| EBITDA yieldHigher is better · 491 reported | 9.3% | 4.0% | 75% | 50% | |
| Free cash flow yieldHigher is better · 199 reported | -2.6% | -2.7% | 52% | 20% | |
| Book yieldHigher is better · 482 reported | 63.6% | 43.8% | 70% | Context only |
Ranking by valuation score
Top 5 and the companies ranked around VREXScores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score